The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens

被引:1289
作者
Wyatt, R
Sodroski, J [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol AIDS,Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
D O I
10.1126/science.280.5371.1884
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The human immunodeficiency virus-type 1 (HIV-1) envelope glycoproteins interact with receptors on the target cell and mediate virus entry by fusing the viral and cell membranes. The structure of the envelope glycoproteins has evolved to fulfill these functions while evading the neutralizing antibody response. An understanding of the viral strategies for immune evasion should guide attempts to improve the immunogenicity of the HIV-1envelope glycoproteins and, ultimately, aid in HIV-1vaccine development.
引用
收藏
页码:1884 / 1888
页数:5
相关论文
共 176 条
  • [31] PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    COOMBS, RW
    COLLIER, AC
    ALLAIN, JP
    NIKORA, B
    LEUTHER, M
    GJERSET, GF
    COREY, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) : 1626 - 1631
  • [32] EFFECTS OF MUTATIONS IN HYPERCONSERVED REGIONS OF THE EXTRACELLULAR GLYCOPROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ON RECEPTOR-BINDING
    CORDONNIER, A
    RIVIERE, Y
    MONTAGNIER, L
    EMERMAN, M
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (10) : 4464 - 4468
  • [33] SINGLE AMINO-ACID CHANGES IN HIV ENVELOPE AFFECT VIRAL TROPISM AND RECEPTOR-BINDING
    CORDONNIER, A
    MONTAGNIER, L
    EMERMAN, M
    [J]. NATURE, 1989, 340 (6234) : 571 - 574
  • [34] HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
    DAAR, ES
    LI, XL
    MOUDGIL, T
    HO, DD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6574 - 6578
  • [35] TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    DAAR, ES
    MOUDGIL, T
    MEYER, RD
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 961 - 964
  • [36] THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS
    DALGLEISH, AG
    BEVERLEY, PCL
    CLAPHAM, PR
    CRAWFORD, DH
    GREAVES, MF
    WEISS, RA
    [J]. NATURE, 1984, 312 (5996) : 763 - 767
  • [37] ISOLATION OF T-CELL TROPIC HTLV-III-LIKE RETROVIRUS FROM MACAQUES
    DANIEL, MD
    LETVIN, NL
    KING, NW
    KANNAGI, M
    SEHGAL, PK
    HUNT, RD
    KANKI, PJ
    ESSEX, M
    DESROSIERS, RC
    [J]. SCIENCE, 1985, 228 (4704) : 1201 - 1204
  • [38] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
    Dean, M
    Carrington, M
    Winkler, C
    Huttley, GA
    Smith, MW
    Allikmets, R
    Goedert, JJ
    Buchbinder, SP
    Vittinghoff, E
    Gomperts, E
    Donfield, S
    Vlahov, D
    Kaslow, R
    Saah, A
    Rinaldo, C
    Detels, R
    OBrien, SJ
    [J]. SCIENCE, 1996, 273 (5283) : 1856 - 1862
  • [39] Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: Identification of critical glycine residues
    Delahunty, MD
    Rhee, I
    Freed, EO
    Bonifacino, JS
    [J]. VIROLOGY, 1996, 218 (01) : 94 - 102
  • [40] Identification of a major co-receptor for primary isolates of HIV-1
    Deng, HK
    Liu, R
    Ellmeier, W
    Choe, S
    Unutmaz, D
    Burkhart, M
    DiMarzio, P
    Marmon, S
    Sutton, RE
    Hill, CM
    Davis, CB
    Peiper, SC
    Schall, TJ
    Littman, DR
    Landau, NR
    [J]. NATURE, 1996, 381 (6584) : 661 - 666